Form 4: BV Financial EVP and CFO Michael Dee Reports Acquisition of Restricted Stock and Stock Options
SEC Form 4 Filing
Michael Dee, EVP and CFO of BV Financial, reports the acquisition of 30,000 shares of restricted stock and 50,000 stock options, along with adjustments to existing holdings.
Summary
- Michael Dee, the EVP and CFO of BV Financial, filed a Form 4 detailing changes in beneficial ownership.
- On September 17, 2024, Dee acquired 30,000 shares of common stock with a value of $0, which are restricted and vest over time.
- He also acquired 50,000 stock options with an exercise price of $14.86, vesting over time and expiring on September 17, 2034.
- Dee directly owns 33,214 shares of common stock.
- Dee indirectly owns 5,310 shares through an ESOP and 38,666 shares through an IRA.
- He also holds 18,370 fully vested stock options with an exercise price of $5.6503, expiring on December 31, 2027.
Sentiment
Score: 6
Explanation: The sentiment is neutral as it's a standard regulatory filing. The acquisition of stock and options could be seen as a positive sign of confidence, but it's a routine part of executive compensation.
Positives
- The acquisition of restricted stock and stock options could align the executive's interests with those of the shareholders.
- The vesting schedules for both the restricted stock and stock options incentivize long-term performance.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Comparison to Industry Standards
- Executive compensation packages often include a mix of salary, stock options, and restricted stock to align management's interests with shareholder value.
- Vesting schedules are common to incentivize long-term commitment and performance, similar to practices at comparable financial institutions.
Stakeholder Impact
- The acquisition of stock and options by the CFO could positively influence shareholder confidence.
- The vesting schedules may incentivize the CFO to focus on long-term value creation.
Key Dates
| Date | Description |
|---|---|
| 12/31/2018 | Date from which fully vested stock options with an exercise price of $5.6503 are exercisable |
| 12/31/2027 | Expiration date for fully vested stock options with an exercise price of $5.6503 |
| 09/17/2024 | Date of transaction: acquisition of restricted stock and stock options |
| 09/17/2025 | First vesting date for 25% of the restricted stock and stock options acquired on 09/17/2024 |
| 09/06/2026 | Date from which the remaining restricted stock and stock options vest at a rate of 25% per year |
| 09/17/2034 | Expiration date for stock options acquired on 09/17/2024 |
| 09/19/2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.